(BIP/H+), a Highly Reactive Organocatalyst
FULL PAPER
MeOH, 96:4, retention time 50.3 min. (S) and 51.9 min. (R). 1H
NMR (CD2Cl2): δ = 8.18 (d, J = 9 Hz, 2 H), 7.54 (d, J = 8.85 Hz,
2 H), 5.28–5.22 (m, 1 H), 3.58 (broad s, 1 H), 2.87–2.82 (m, 2 H),
2.49–2.43 (m, 1 H), 1.05–0.95 (m, 6 H). 13C NMR (CDCl3): δ =
215.6, 146.6, 126.8, 123.5, 71.9, 51.4, 35.1, 9.9, 7.4 ppm. MS
(FAB+): m/z (%) = 260 (100) [M + Na]+, 238 (20) [M + H]+, 212
2.19 (s, 3 H) ppm. 13C NMR (CD2Cl2): δ = 208.8, 150.8, 147.7, (21). HRMS: calcd. for C12H15NO4Na [M + Na]+ 260.089878;
129.4, 124.0, 69.3, 51.8, 30.8 ppm. MS (FAB+): m/z (%) = 232
(100) [M + Na]+, 212 (40), 210 (35) [M + H]+. HRMS: calcd. for
C10H11NO4Na [M + Na]+ 232.058578; found 232.053874.
found 260.090584.
3-[Hydroxy(4-nitrophenyl)methyl]-1,1-diphenylsilinan-4-one (13a
and 13b): Rf (hexanes/EtOAc, 8:2, syn) = 0.4, Rf (hexanes/EtOAc,
8:2, anti) = 0.35. HPLC: Chiralcel AD-H®, hexanes/MeOH, 96:4,
retention time for syn-13b 34.4 min and 36.7 min; anti-13a 71.1 min
and 96.3 min. syn-13b: 1H NMR (CDCl3): δ = 8.15 (d, J = 8.7 Hz,
2 H), 7.39 (d, J = 8.7 Hz, 2 H), 7.37–7.29 (m, 10 H), 5.35 (s, 1 H),
3.47 (d, J = 3 Hz, 1 H), 2.88–2.84 (m, 1 H), 2.82–2.64 (m, 2 H),
1.47–1.35 (m, 4 H) ppm. 13C NMR (CDCl3): δ = 216.6, 148.9,
147.1, 134.7, 130.7, 128.5, 128.4, 127.1, 123.8, 71.8, 52.8, 39.0, 10.4,
8.2 ppm. anti-13a: 1H NMR (CDCl3): δ = 8.15 (d, J = 8.7 Hz, 2
H), 7.39 (d, J = 8.7 Hz, 2 H), 7.37–7.29 (m, 10 H), 4.96 (d, J =
8 Hz, 1 H), 3.7 (br., 1 H), 2.96–2.92 (m, 1 H), 2.75–2.69 (m, 2 H),
1.67–1.58 (m 4 H) ppm. 13C NMR (CDCl3): δ = 216.6, 148.9,
147.1, 134.7, 130.7, 128.5, 128.4, 127.1, 123.8, 76.3, 53.3, 39.4, 14.3,
10.8 ppm.
(S)-2-(1-Isopropylpyrrolidin-2-yl)-5,6-dimethyl-1H-benzimidazole
(5): 1 (50 mg, 0.23 mmol) and TFA (18 µL, 0.23 mmol) were stirred
in acetone for 10 min, and NaBH3CN (30 mg, 0.5 mmol) was
added in portions. After 24 h at room temperature, the resulting
solution was treated with water and Na2CO3. The reaction mixture
was extracted with EtOAc, and the resulting organic layer was
dried with MgSO4. The solvent was evaporated in vacuo to afford
5 as a white powder (39 mg, 65 % yield). M.p. 160–178 °C. IR
(KBr): ν = 2966, 1635, 1417, 1309 cm–1. 1H NMR (CDCl3): δ =
˜
7.25 (s, 2 H), 4.11–4.08 (m, 1 H), 3.15–3.05 (m, 1 H), 2.85–2.75 (m,
1 H), 2.60–2.40 (m, 1 H), 2.28 (s, 6 H), 2.25–2.15 (m, 1 H), 1.95–
1.75 (m, 1 H), 1.73–1.65 (m, 2 H), 0.99 (d, J = 6.4 Hz, 3 H), 0.95
(d, J = 6.4 Hz, 3 H) ppm. 13C NMR ([D6]DMSO): δ = 159.2, 131.3,
115.4, 59.7, 53, 50.3, 33.8, 24.7, 22.2, 20.7, 19.4 ppm. MS (FAB+):
m/z (%) = 280 [M + Na]+, 258 (100) [M + H]+, 257 (26), 256 (80),
214 (65), 212 (22). HRMS: calcd. for C16H24N3 [M + H]+
258.196543; found 258.197023.
4-Hydroxy-4-(pyridin-4-yl)butan-2-one (15b):[29] Rf (CH2Cl2/diethyl
ether, 8:2) = 0.5. HPLC: Chiralcel AD-H®, hexanes/MeOH, 90:10,
retention time 15.5 min. (S) and 16.7 min. (R). 1H NMR (CD2Cl2):
δ = 8.49 (d, J = 6 Hz, 2 H), 7.22 (d, J = 6 Hz, 2 H), 5.08 (t, J =
6.4 Hz, 1 H), 3.65 (br., 1 H), 2.76 (d, J = 5.3 Hz, 2 H), 2.15 (s, 3
H) ppm. 13C NMR (CDCl3): δ = 208.4, 151.6, 149.9, 120.5, 68.4,
51.2, 30.7 ppm. MS (EI): m/z (%) = 132 (20), 107,(100), 106,(37),
78(55).
2-[Hydroxy-(4-nitrophenyl)methyl]cyclopentanone (8a and 9a):[18b]
Rf (hexanes/EtOAc, 7:3) = 0.4. HPLC: Chiralcel AD-H®, hexanes/
MeOH, 95:5, retention time for syn-9a 26.7 min and 42 min; anti-
8a 52.6 min and 55.3 min. anti-8a: 1H NMR (CD2Cl2): δ = 8.18 (d,
J = 10.6 Hz, 2 H), 7.53 (d, J = 10.2 Hz, 2 H), 4.82 (d, J = 9.0 Hz,
1 H), 4.67 (s, 1 H), 2.30–1.50 (m, 7 H) ppm. 13C NMR (CDCl3): δ
= 240.1, 150.8, 148.0, 126.8, 123.9, 74.8, 55.4, 39.0, 27.2, 20.7 ppm.
2-Methyl-2-(3-oxobutyl)cyclopentane-1,3-dione (16a):[24] 2-Methyl-
cyclopentane-1,3-dione (2 mmol) was placed in CH3CN (3 mL),
and triethylamine (1 mL) was added, followed by methylvinyl
ketone (200 µL, 2.4 mmol). The reaction mixture was stirred at
room temperature. The reaction progress was monitored by TLC
(hexanes/EtOAc, 1:1). The solvents were removed under vacuum,
and the residue was purified through chromatography over silica
gel to give 16a as an oil (100% yield); Rf (hexanes/EtOAc, 1:1) =
1
syn-9a: H NMR (CDCl3): δ = 8.18 (d, J = 7.2 Hz, 2 H), 7.53 (d,
J = 7.5 Hz, 2 H), 5.38 (m, 1 H), 2.59 (d, J = 4.9 Hz, 1 H), 2.30–
1.50 (m, 7 H) ppm. 13C NMR (CDCl3): δ = 220.1, 149.4, 127.8,
123.4, 70.9, 56.3, 39.2, 22.8, 20.7 ppm. MS (FAB+): m/z (%) = 258
(100) [M + Na]+ , 218 (37), 212 (42). HRMS: calcd. for
C12H13NO4Na [M + Na]+ 258.074228; found 258.074435.
1
0.4. H NMR (CDCl3): δ = 2.89–2.73 (m, 4 H), 2.47 (t, J = 7 Hz,
2-[Hydroxy(4-nitrophenyl)methyl]cyclohexanone (8b and 9b): Rf
(hexanes/EtOAc, 7:3, syn) = 0.25; Rf (hexanes/EtOAc, 7:3, anti) =
0.2. HPLC: Chiralcel AD-H®, hexanes/MeOH, 90:10, retention
time syn-9b 14.6 min and 16.1 min; anti-8b 17.4 min and 24.2 min.
2 H), 2.12 (s, 3 H), 1.91 (t, J = 5 Hz, 2 H), 1.12 (s, 3 H) ppm. 13C
NMR (CDCl3): δ = 215.7, 207.8, 55.1, 37.4, 34.7, 30.0, 27.8, 19.1
ppm. MS (FAB+): m/z (%) = 183 (100) [M + H]+. HRMS: calcd.
for C10H15O3 [M + H]+ 183.102120; found 183.10190.
1
anti-8b: H NMR (CDCl3) δ = 8.19 (d, J = 10.3 Hz, 2 H), 7.50 (d,
2-Methyl-2-(3-oxobutyl)cyclohexane-1,3-dione (16b):[24] Compound
16b was prepared following the same procedure as described for
16a above. Rf (hexanes/EtOAc, 1:1) = 0.4. H NMR (CDCl3): δ =
2.79–2.59 (m, 4 H), 2.36 (t, J = 7 Hz, 2 H), 2.13 (s, 3 H), 2.09–2.01
(m, 2 H), 1.99–1.85 (m, 2 H), 1.26 (s, 3 H) ppm. 13C NMR
(CDCl3): δ = 210.0, 207.5, 64.3, 38.4, 37.8, 29.9, 29.6, 20.0, 17.6
ppm. MS (FAB+): m/z (%) = 197 (100) [M + H]+. HRMS: cacld.
for C11H17O3 [M + H]+ 197.117770; found 197.118217.
J = 10.2 Hz, 2 H), 4.88 (dd, J = 6.2 and 3.7 Hz, 1 H), 4.09 (d, J =
4 Hz, 1 H), 2.64–2.28 (m, 3 H), 2.14–2.06 (m, 1 H), 1.83–1.30 (m,
5 H) ppm. 13C NMR (CDCl3): δ = 214.7, 148.4, 127.9, 123.6, 74.0,
57.2, 42.7, 30.7, 27.6, 24.7 ppm. syn-9b: 1H NMR (CDCl3): δ =
8.21 (d, J = 7.5 Hz, 2 H), 7.49 (d, J = 7.5 Hz, 2 H), 5.49 (s, 1 H),
3.20 (d, J = 3 Hz, 1 H), 2.67–2.53 (m, 3 H), 2.16–2.07 (m, 1 H),
1.89–1.45 (m, 5 H) ppm. 13C NMR (CDCl3): δ = 213.9, 147.6,
126.6, 123.4, 70.1, 56.8, 42.6, 27.8, 25.9, 24.8 ppm. MS (FAB+):
m/z (%) = 272 (100) [M + Na]+, 232 (30), 212 (49). HRMS: calcd.
for C13H15NO4Na [M + Na]+ 272.089878; found 272.090203.
1
7α-Methyl-2,3,7,7α-tetrahydro-6H-indene-1,5-dione (17a):[22c] In a
2 mL flask, 1 (11 mg, 48 µmol), TFA (3.9 µL, 50 µmol) and 16a
(98 mg, 5 mmol) were mixed in THF (1 mL), and the reaction mix-
1-Hydroxy-2-methyl-1-(4-nitrophenyl)pentane-3-one (8c and 9c):[18c]
Rf (hexanes/EtOAc, 7:3) = 0.3. HPLC: Chiralcel OD®, hexanes/
ture was stirred at room temperature. The reaction progress was
1
MeOH, 92:8, retention time for syn-9c 14.9 min and 15.4 min; anti- monitored by H NMR analysis. The crude reaction mixture was
1
8c 13.8 min and 16.4 min. anti-8c: H NMR (CDCl3): δ = 8.22 (d,
purified by flash column chromatography on silica gel (hexanes/
J = 8.8 Hz, 2 H), 7.51 (d, J = 8.5 Hz, 2 H), 4.88 (d, J = 7.5 Hz, 1 EtOAc, 9:1) to give ketone 17a. HPLC: Chiralcel OD®, hexanes/
H), 2.95–2.91 (m, 1 H), 2.55–2.51 (m, 1 H), 2.49–2.43 (m, 1 H), MeOH, 96:4, retention time 31.9 min and 36.7 min. 1H NMR
1.05–0.95 (m, 6 H) ppm. 13C NMR (CDCl3): δ = 215.6, 149.6, (CDCl3): δ = 5.98 (s, 1 H), 3.05–2.92 (m, 1 H), 2.85–2.77 (m, 2 H),
127.4, 123.7, 75.6, 52.2, 36.4, 14.5, 7.5 ppm. syn-9c: 1H NMR
2.58–2.47 (m, 2 H), 2.17–2.04 (m, 2 H), 1.98–1.84 (m, 1 H), 1.33
(CDCl3): δ = 8.22 (d, J = 8.8 Hz, 2 H), 7.51 (d, J = 8.5 Hz, 2 H), (s, 3 H) ppm. 13C NMR (CDCl3): δ = 214.3, 196.0, 167.6, 121.8,
5.23 (d, J = 3 Hz, 1 H), 2.85–2.75 (m, 1 H), 2.55–2.51 (m, 1 H), 94.4, 32.6, 27.6, 24.7, 18.4 ppm. MS (FAB+): m/z (%) = 165 (100)
Eur. J. Org. Chem. 2007, 167–177
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
175